Ricerca: al via a Neuromed e Polo Neurobiotech la settimana della scienza - Tiscali Notizie
Telethon finanzia la ricerca Neuromed: Vittorio Maglione, lab malattie rare - YouTube
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Il ricercatore Vittorio Maglione alla prestigiosa Gordon Conference – quotidianomolise.com
PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease
Vittorio Maglione (@VittorioMaglio1) / Twitter
Telethon finanzia la ricerca sulle malattie rare della Fondazione Neuromed - Istituto Neuromed
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience
Pozzilli: Vittorio Maglione , ricercatore del Neuromed invitato alla Gordon Conference. Presenterà i suoi lavori sui glicolipidi e sfingolipidi. - News Della Valle
Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
NEUROMED - Il ricercatore Vittorio Maglione relatore al corso della Federazione Europea delle Società Biochimiche | Molise Network
PDF) Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Vittorio Maglione | Neurology Conferences 2018 | Neuroscience Conferences | Neurology Congress 2018
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio Maglione (@VittorioMaglio1) / Twitter
NEUROMED INCONTRA PAPA FRANCESCO | inSalute – Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
MALATTIE RARE. L'IMPORTANZA DELLA CONOSCENZA | inSalute – Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
sergio – SPHINGOLIPID CLUB
Malattie rare, intervista a Vittorio Maglione ricercatore Neuromed - Adnkronos.com
PDF) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
